S 4160
116th Congress
Senate
Health
Cardiovascular and respiratory health
Emergency medical services and trauma care
Health care coverage and access
Health facilities and institutions
Health programs administration and funding
Hospital care
Infectious and parasitic diseases
Inflation and prices
Prescription drugs
A bill to enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes.
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 2, 2020
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S4225-4226)
Jul 2, 2020
Introduced in Senate
Plain-English summary
This bill waives certain eligibility requirements for hospitals participating in the 340B drug discount program (i.e., a program that allows entities to receive covered outpatient drugs at reduced prices from manufacturers) during the COVID-19 (i.e., coronavirus disease 2019) public health emergency. Specifically, the bill waives the required minimum proportion of low-income patients served for hospitals that began participating in the program during or prior to the COVID-19 emergency.
What's happening now
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S4225-4226)
Committees of jurisdiction
1